Portage Biotech Inc.
NASDAQ:PRTG
4.99 (USD) • At close January 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.098 | 0 | 0 | 0 | 0.042 | 0.241 | 0.645 | 1.593 | 0.311 | 0 | 0.01 | 0.042 | 0.076 | 0.021 | 0 | 0 |
| Cost of Revenue
| 0.054 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.957 | 0 | 0 |
| Gross Profit
| -0.054 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.098 | 0 | 0 | 0 | 0.042 | 0.241 | 0.645 | 1.593 | 0.311 | 0 | 0.01 | 0.042 | 0.076 | -0.936 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | -44.54 | 0 | 0 |
| Reseach & Development Expenses
| 12.535 | 8.214 | 6.769 | 7.312 | 4.108 | 0.762 | 0.561 | 32.45 | 4.577 | 2.929 | 1.136 | 0.032 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 5.664 | 8.361 | 8.819 | 5.128 | 1.87 | 1.868 | 1.55 | 2.557 | 4.516 | 1.297 | 1.653 | 1.558 | 1.568 | 2.354 | 2.475 | 0.578 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.014 | 0.171 | 0.032 | 0.136 | 0.085 | 0.053 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.664 | 8.361 | 8.819 | 5.128 | 1.87 | 1.868 | 1.55 | 2.557 | 4.516 | 1.297 | 1.653 | 1.558 | 1.6 | 2.49 | 2.56 | 0.631 | 0.729 | 0.675 | 2.2 | 4.36 | 1.071 | 0.227 | 0.688 | 0.418 | 0.007 | 0.013 | 0.046 |
| Other Expenses
| 0 | 0 | 0 | -1.256 | 0 | 0.134 | 0.116 | 0.485 | 0.095 | 0.092 | -0.013 | -0.494 | 0.087 | 0.997 | 0.718 | -0.095 | 0 | 0.675 | 0 | 0 | 0 | 0 | 0.023 | 0.022 | 0.015 | 0.304 | 0.344 |
| Operating Expenses
| 18.199 | 16.576 | 15.588 | 12.44 | 5.978 | 2.764 | 2.227 | 35.491 | 9.188 | 4.317 | 2.789 | 1.235 | 1.687 | 3.487 | 3.279 | 0.536 | 0.729 | 0.675 | 2.2 | 4.36 | 1.071 | 0.227 | 0.711 | 0.44 | 0.021 | 0.316 | 0.39 |
| Operating Income
| -18.253 | -16.575 | -15.588 | -12.44 | -5.978 | -2.764 | -2.227 | -35.491 | -9.188 | -4.317 | -6.302 | -1.444 | -2.474 | -3.889 | -3.175 | -0.544 | -0.487 | -0.033 | -3.934 | -4.048 | -1.071 | -0.217 | -0.669 | -0.364 | -0.957 | -0.317 | -0.397 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.677 | 0 | 0 | 0 | -12.979 | -2.019 | -0.052 | -2.469 | -12.997 | 0 | -20.84 | -15.965 | -4.783 | -45.553 | 0 | 0 |
| Total Other Income Expenses Net
| -67.444 | -105.947 | 0.771 | -2.452 | -0.549 | -0.83 | 125.976 | -0.552 | -0.007 | -0.116 | -3.993 | -0.113 | -0.875 | 0.171 | -0.246 | -0.068 | -0.067 | 0.46 | -1.859 | 0.199 | 0.036 | 0.009 | -0.161 | -0.729 | 0 | 0 | 0 |
| Income Before Tax
| -85.697 | -122.522 | -14.817 | -14.892 | -5.084 | -3.594 | 123.741 | -0.641 | -9.195 | -4.341 | -6.627 | -1.447 | -3.262 | -4.287 | -3.421 | -0.594 | -0.625 | 0.427 | -9.188 | -3.718 | -1.035 | -0.207 | -0.83 | -1.093 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.699 | 0 | 0 | 0 | -14.169 | -2.59 | 0.662 | -5.766 | -11.938 | 0 | -19.964 | -19.808 | -14.357 | 0 | 0 | 0 |
| Income Tax Expense
| -10.548 | -17.856 | 4.352 | 2.297 | 2.165 | -0.217 | -126 | -52.342 | -3.489 | -1.219 | 0.003 | 0.002 | 0.002 | -0.053 | 0.678 | 0.002 | 0.068 | 0.569 | 0.167 | 0.129 | -0.036 | 0.001 | 0.167 | 0.725 | 0 | 0 | 0.007 |
| Net Income
| -75.339 | -104.611 | -19.169 | -17.189 | -7.249 | -2.635 | 123.741 | 16.299 | -5.706 | -3.118 | -6.305 | -1.447 | -2.476 | -3.836 | -3.853 | -0.546 | -0.556 | -0.142 | -4.104 | -4.18 | -1.038 | -0.218 | -0.836 | -1.09 | -0.957 | -0.317 | -0.397 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.699 | 0 | 0 | 0 | -13.024 | -2.301 | -0.221 | -2.576 | -13.421 | 0 | -20.935 | -19.937 | -14.31 | -45.553 | 0 | 0 |
| EPS
| -3.7 | -6.49 | -1.47 | -1.47 | -0.66 | -0.55 | 46.21 | 6.42 | -2.38 | -1.61 | -3.89 | -1.77 | -3.15 | -4.88 | -8.97 | -1.81 | -1.93 | -0.52 | -26.01 | -35.55 | -28.31 | -21.08 | -118.28 | -168.85 | -165.44 | -103.87 | -251.36 |
| EPS Diluted
| -3.7 | -6.49 | -1.47 | -1.47 | -0.66 | -0.55 | 45.89 | 5.99 | -2.38 | -1.61 | -3.89 | -1.77 | -3.15 | -4.88 | -8.97 | -1.81 | -1.93 | -0.52 | -26.01 | -35.55 | -28.31 | -21.08 | -118.28 | -168.85 | -165.44 | -103.87 | -251.36 |
| EBITDA
| -18.199 | -15.775 | 0 | 0 | 0 | -0.65 | -2.067 | -35.331 | -0 | -4.317 | -6.625 | -1.468 | -2.485 | -3.711 | -3.296 | -0.493 | -0.553 | -0.49 | -2.341 | -4.013 | -1.04 | -0.217 | -0.646 | -0.342 | -0.942 | -0.304 | -0.378 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.533 | 0 | 0 | 0 | -10.56 | -1.445 | -0.76 | 2.916 | -14.057 | 0 | -21.717 | -11.572 | 5.083 | -44.85 | 0 | 0 |